BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ilyas M, Straub J, Tomlinson IP, Bodmer WF. Genetic pathways in colorectal and other cancers. Eur J Cancer. 1999;35:335-351. [PMID: 10711241 DOI: 10.1016/s0959-8049(99)00298-1] [Cited by in Crossref: 101] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Ibrahem S, Al-Ghamdi S, Baloch K, Muhammad B, Fadhil W, Jackson D, Nateri AS, Ilyas M. STAT3 paradoxically stimulates β-catenin expression but inhibits β-catenin function. Int J Exp Pathol 2014;95:392-400. [PMID: 25348333 DOI: 10.1111/iep.12102] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
2 Richter H, Slezak P, Walch A, Werner M, Braselmann H, Jaramillo E, Ost A, Hirata I, Takahama K, Zitzelsberger H. Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms. Am J Pathol. 2003;163:287-294. [PMID: 12819033 DOI: 10.1016/s0002-9440(10)63652-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
3 Tan CW, Gardiner BS, Hirokawa Y, Layton MJ, Smith DW, Burgess AW. Wnt signalling pathway parameters for mammalian cells. PLoS One. 2012;7:e31882. [PMID: 22363759 DOI: 10.137/journal.pone.0031882] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Stintzing S. Management of colorectal cancer. F1000Prime Rep 2014;6:108. [PMID: 25580262 DOI: 10.12703/P6-108] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
5 Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer. 2003;2:41. [PMID: 14672538 DOI: 10.1186/1476-4598-2-41] [Cited by in Crossref: 118] [Cited by in F6Publishing: 109] [Article Influence: 6.2] [Reference Citation Analysis]
6 Buisine MP, Wacrenier A, Mariette C, Leteurtre E, Escande F, Aissi S, Ketele A, Leclercq A, Porchet N, Lesuffleur T. Frequent mutations of the CA simple sequence repeat in intron 1 of EGFR in mismatch repair-deficient colorectal cancers. World J Gastroenterol 2008; 14(7): 1053-1059 [PMID: 18286687 DOI: 10.3748/wjg.14.1053] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
7 Thomas V, Cotter MB, Tosetto M, Khaw YL, Geraghty R, Winter DC, Ryan EJ, Sheahan K, Furney SJ. Personalised mapping of tumour development in synchronous colorectal cancer patients. NPJ Genom Med 2020;5:27. [PMID: 32655884 DOI: 10.1038/s41525-020-0134-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Tan CW, Hirokawa Y, Burgess AW. Analysis of Wnt signalling dynamics during colon crypt development in 3D culture. Sci Rep 2015;5:11036. [PMID: 26087250 DOI: 10.1038/srep11036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
9 Kam Y, Quaranta V. Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools. PLoS One 2009;4:e4580. [PMID: 19238201 DOI: 10.1371/journal.pone.0004580] [Cited by in Crossref: 112] [Cited by in F6Publishing: 100] [Article Influence: 8.6] [Reference Citation Analysis]
10 Hu T, Kumar Y, Shazia I, Duan SJ, Li Y, Chen L, Chen JF, Yin R, Kwong A, Leung GK, Mat WK, Wu Z, Long X, Chan CH, Chen S, Lee P, Ng SK, Ho TYC, Yang J, Ding X, Tsang SY, Zhou X, Zhang DH, Zhou EX, Xu L, Poon WS, Wang HY, Xue H; International Cancer Genome Consortium. Forward and reverse mutations in stages of cancer development. Hum Genomics 2018;12:40. [PMID: 30134973 DOI: 10.1186/s40246-018-0170-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Rooney JP, Patil A, Zappala MR, Conklin DS, Cunningham RP, Begley TJ. A molecular bar-coded DNA repair resource for pooled toxicogenomic screens. DNA Repair (Amst) 2008;7:1855-68. [PMID: 18723126 DOI: 10.1016/j.dnarep.2008.07.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Sun Y, Ji P, Chen T, Zhou X, Yang D, Guo Y, Liu Y, Hu L, Xia D, Liu Y, Multani AS, Shmulevich I, Kucherlapati R, Kopetz S, Sood AK, Hamilton SR, Sun B, Zhang W. MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer. J Pathol 2017;241:67-79. [PMID: 27741356 DOI: 10.1002/path.4823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rustagi T, Rangasamy P, Myers M, Sanders M, Vaziri H, Wu GY, Birk JW, Protiva P, Anderson JC. Sessile serrated adenomas in the proximal colon are likely to be flat, large and occur in smokers. World J Gastroenterol 2013; 19(32): 5271-5277 [PMID: 23983429 DOI: 10.3748/wjg.v19.i32.5271] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
14 Lawrie LC, Dundas SR, Curran S, Murray GI. Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer 2004;90:1955-60. [PMID: 15138477 DOI: 10.1038/sj.bjc.6601828] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
15 Ibrahem S, Seth R, O'Sullivan B, Fadhil W, Taniere P, Ilyas M. Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection. Int J Exp Pathol 2010;91:500-5. [PMID: 21199003 DOI: 10.1111/j.1365-2613.2010.00733.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
16 Lee W, Belkhiri A, Lockhart AC, Merchant N, Glaeser H, Harris EI, Washington MK, Brunt EM, Zaika A, Kim RB, El-Rifai W. Overexpression of OATP1B3 confers apoptotic resistance in colon cancer. Cancer Res 2008;68:10315-23. [PMID: 19074900 DOI: 10.1158/0008-5472.CAN-08-1984] [Cited by in Crossref: 94] [Article Influence: 6.7] [Reference Citation Analysis]
17 Baran AA, Silverman KA, Zeskand J, Koratkar R, Palmer A, McCullen K, Curran WJ Jr, Edmonston TB, Siracusa LD, Buchberg AM. The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression. Genome Res 2007;17:566-76. [PMID: 17387143 DOI: 10.1101/gr.6089707] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
18 Sun Y, Yokoi K, Li H, Gao J, Hu L, Liu B, Chen K, Hamilton SR, Fan D, Sun B, Zhang W. NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models. Clin Cancer Res 2011;17:4331-40. [PMID: 21622717 DOI: 10.1158/1078-0432.CCR-11-0226] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
19 Bhagat R, Chadaga S, Premalata CS, Ramesh G, Ramesh C, Pallavi VR, Krishnamoorthy L. Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development. Cell Oncol (Dordr) 2012;35:473-9. [PMID: 23055343 DOI: 10.1007/s13402-012-0106-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
20 Satow R, Hirano T, Batori R, Nakamura T, Murayama Y, Fukami K. Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells. Proc Natl Acad Sci U S A 2014;111:13505-10. [PMID: 25197077 DOI: 10.1073/pnas.1405374111] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
21 Brandal P, Bjerkehagen B, Heim S. Molecular cytogenetic characterization of tenosynovial giant cell tumors. Neoplasia 2004;6:578-83. [PMID: 15548367 DOI: 10.1593/neo.04202] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
22 Ismail NI, Othman I, Abas F, H Lajis N, Naidu R. Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. Int J Mol Sci 2019;20:E2454. [PMID: 31108984 DOI: 10.3390/ijms20102454] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
23 Romijn LB, Almet AA, Tan CW, Osborne JM. Modelling the effect of subcellular mutations on the migration of cells in the colorectal crypt. BMC Bioinformatics 2020;21:95. [PMID: 32126976 DOI: 10.1186/s12859-020-3391-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Lee W, Belkhiri A, Lockhart AC, Merchant N, Glaeser H, Harris EI, Washington MK, Brunt EM, Zaika A, Kim RB, El-Rifai W. Overexpression of OATP1B3 confers apoptotic resistance in colon cancer. Cancer Res 2008;68:10315-23. [PMID: 19074900 DOI: 10.1158/0008-5472.CAN-08-1984] [Cited by in Crossref: 91] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
25 Maeda K, Shibutani M, Otani H, Nagahara H, Ikeya T, Iseki Y, Tanaka H, Muguruma K, Hirakawa K. Inflammation-based factors and prognosis in patients with colorectal cancer. World J Gastrointest Oncol 2015; 7(8): 111-117 [PMID: 26306143 DOI: 10.4251/wjgo.v7.i8.111] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
26 Kim YS, Deng G. Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia. Gut Liver 2007;1:1-11. [PMID: 20485652 DOI: 10.5009/gnl.2007.1.1.1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
27 Gu C, Begley TJ, Dedon PC. tRNA modifications regulate translation during cellular stress. FEBS Lett 2014;588:4287-96. [PMID: 25304425 DOI: 10.1016/j.febslet.2014.09.038] [Cited by in Crossref: 99] [Cited by in F6Publishing: 85] [Article Influence: 12.4] [Reference Citation Analysis]
28 Schor SL, Schor AM. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res 2001;3:373-9. [PMID: 11737888 DOI: 10.1186/bcr325] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 3.6] [Reference Citation Analysis]
29 Roschke AV, Stover K, Tonon G, Schäffer AA, Kirsch IR. Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability. Neoplasia 2002;4:19-31. [PMID: 11922387 DOI: 10.1038/sj.neo.7900197] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 3.5] [Reference Citation Analysis]
30 Kelloff GJ, Sigman CC. Cancer biomarkers: selecting the right drug for the right patient. Nat Rev Drug Discov 2012;11:201-14. [PMID: 22322254 DOI: 10.1038/nrd3651] [Cited by in Crossref: 186] [Cited by in F6Publishing: 150] [Article Influence: 18.6] [Reference Citation Analysis]
31 van Geelen CM, de Vries EG, Le TK, van Weeghel RP, de Jong S. Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines. Br J Cancer 2003;89:363-73. [PMID: 12865931 DOI: 10.1038/sj.bjc.6601065] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
32 Rustagi T, Rangasamy P, Myers M, Sanders M, Vaziri H, Wu GY, Birk JW, Protiva P, Anderson JC. Sessile serrated adenomas in the proximal colon are likely to be flat, large and occur in smokers. World J Gastroenterol. 2013;19:5271-5277. [PMID: 23983429 DOI: org/10.3748/wjg.v19.i32.5271] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Niu L, Li S, Liang H, Li H. The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population. PLoS One 2015;10:e0135822. [PMID: 26275295 DOI: 10.1371/journal.pone.0135822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
34 Fadhil W, Kindle K, Jackson D, Zaitoun A, Lane N, Robins A, Ilyas M. DNA content analysis of colorectal cancer defines a distinct 'microsatellite and chromosome stable' group but does not predict response to radiotherapy. Int J Exp Pathol 2014;95:16-23. [PMID: 24456329 DOI: 10.1111/iep.12070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
35 Begley U, Dyavaiah M, Patil A, Rooney JP, DiRenzo D, Young CM, Conklin DS, Zitomer RS, Begley TJ. Trm9-catalyzed tRNA modifications link translation to the DNA damage response. Mol Cell 2007;28:860-70. [PMID: 18082610 DOI: 10.1016/j.molcel.2007.09.021] [Cited by in Crossref: 212] [Cited by in F6Publishing: 198] [Article Influence: 15.1] [Reference Citation Analysis]
36 Davies JA. Inverse Correlation Between an Organ's Cancer Rate and Its Evolutionary Antiquity. Organogenesis 2004;1:60-3. [PMID: 20140231 DOI: 10.4161/org.1.2.1338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
37 Soliman AS, Bondy ML, El-Badawy SA, Mokhtar N, Eissa S, Bayoumy S, Seifeldin IA, Houlihan PS, Lukish JR, Watanabe T. Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients. Br J Cancer. 2001;85:1037-1046. [PMID: 11592777 DOI: 10.1038/sj.bjc.6691838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Diggs DL, Huderson AC, Harris KL, Myers JN, Banks LD, Rekhadevi PV, Niaz MS, Ramesh A. Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2011;29:324-357. [PMID: 22107166 DOI: 10.1080/10590501.2011.629974] [Cited by in Crossref: 139] [Cited by in F6Publishing: 122] [Article Influence: 13.9] [Reference Citation Analysis]
39 Tan CW, Hirokawa Y, Gardiner BS, Smith DW, Burgess AW. Colon cryptogenesis: asymmetric budding. PLoS One 2013;8:e78519. [PMID: 24205248 DOI: 10.1371/journal.pone.0078519] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
40 Oliveira LA, Oshima CTF, Soffner PA, Silva MS, Lins RR, Malinverni ACM, Waisberg J. THE CANONICAL WNT PATHWAY IN GASTRIC CARCINOMA. Arq Bras Cir Dig 2019;32:e1414. [PMID: 30624523 DOI: 10.1590/0102-672020180001e1414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
41 Farinha P, Pinho JO, Matias M, Gaspar MM. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs. Drug Deliv Transl Res 2021. [PMID: 33616870 DOI: 10.1007/s13346-021-00916-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Valtorta S, Nicolini G, Tripodi F, Meregalli C, Cavaletti G, Avezza F, Crippa L, Bertoli G, Sanvito F, Fusi P, Pagliarin R, Orsini F, Moresco RM, Coccetti P. A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer. Invest New Drugs 2014;32:1123-33. [PMID: 25134489 DOI: 10.1007/s10637-014-0148-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
43 Tan CW, Gardiner BS, Hirokawa Y, Layton MJ, Smith DW, Burgess AW. Wnt signalling pathway parameters for mammalian cells. PLoS One 2012;7:e31882. [PMID: 22363759 DOI: 10.1371/journal.pone.0031882] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 8.1] [Reference Citation Analysis]
44 Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, Yang VW. Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 2004;23:395-402. [PMID: 14724568 DOI: 10.1038/sj.onc.1207067] [Cited by in Crossref: 202] [Cited by in F6Publishing: 211] [Article Influence: 11.2] [Reference Citation Analysis]
45 Soliman AS, Bondy ML, El-Badawy SA, Mokhtar N, Eissa S, Bayoumy S, Seifeldin IA, Houlihan PS, Lukish JR, Watanabe T, Chan AO, Zhu D, Amos CI, Levin B, Hamilton SR. Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients. Br J Cancer 2001;85:1037-46. [PMID: 11592777 DOI: 10.1054/bjoc.2001.1838] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
46 Paramita P, Subramaniam VD, Murugesan R, Gopinath M, Ramachandran I, Ramalingam S, Sun XF, Banerjee A, Marotta F, Pathak S. Evaluation of potential anti-cancer activity of cationic liposomal nanoformulated Lycopodium clavatum in colon cancer cells. IET Nanobiotechnol 2018;12:727-32. [PMID: 30104445 DOI: 10.1049/iet-nbt.2017.0106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]